Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
about
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimensHydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxideHydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoterOligopeptide inhibition of class I ribonucleotide reductases.Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
P2860
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@ast
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@en
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@nl
type
label
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@ast
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@en
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@nl
prefLabel
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@ast
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@en
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@nl
P2093
P2860
P1433
P1476
Hydroxyurea to inhibit human immunodeficiency virus-1 replication.
@en
P2093
P2860
P304
P356
10.1592/PHCO.19.3.196.30913
P407
P577
1999-02-01T00:00:00Z